RXO, Inc.
No SEC Form 4 filings for $RXO in the last 30 days.
According to a May 14, 2026 SEC 13F filing, MFN Partners Management, LP bought 532,276 additional RXO shares, valuing the trade at about $7.81 million based on first-quarter average pricing. The fund’s RXO position rose by about $62.39 million and represented 8.61% of its reportable 13F assets.
Stifel has upgraded RXO Inc. (NYSE:RXO) to a Buy rating from Hold, setting a price target of $22, signifying a potential 26% upside. The upgrade is based on improving brokerage fundamentals and internal company strengths, despite soft Q1 2026 results. Analysts believe a recent stock decline, partly due to a Supreme Court ruling, presents a favorable entry point for investors.
Massachusetts Financial Services Co. MA significantly increased its stake in Rxo Inc. (NYSE:RXO) during the fourth quarter, purchasing an additional 190,583 shares to own a total of 1,110,413 shares valued at approximately $14.04 million. Despite the stock opening up 9.3% at $18.01 recently, Rxo Inc. reported a quarterly EPS miss and an 11.9% year-over-year revenue decline. Analysts currently maintain a "Hold" rating on RXO with an average price target of $15.77.
